96
Addiction is a chronic Addiction is a chronic disease and it matters disease and it matters Richard A. Rawson, Ph.D, Professor Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine David Geffen School of Medicine University of California at Los Angeles University of California at Los Angeles www.uclaisap.org [email protected] Supported by: Supported by: National Institute on Drug Abuse (NIDA) National Institute on Drug Abuse (NIDA) Pacific Southwest Technology Transfer Center (SAMHSA) Pacific Southwest Technology Transfer Center (SAMHSA) International Network of Treatment and Rehabilitation Resource International Network of Treatment and Rehabilitation Resource Centres (UNODC) Centres (UNODC)

Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Embed Size (px)

DESCRIPTION

Demonization Criminalization Psychiatric views Socialization Medicalization Addiction Paradigms Sinful/Immoral Criminal/Illegal Mental Disorder- DSM Learned Behavior/Habit Acute (Brain) Disease Neuro-Science & Longitudinal Research Chronic Illness Leshner, 2001; Anglin et al., 1997

Citation preview

Page 1: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Addiction is a chronic disease Addiction is a chronic disease and it mattersand it matters

Richard A. Rawson, Ph.D, ProfessorRichard A. Rawson, Ph.D, ProfessorSemel Institute for Neuroscience and Human BehaviorSemel Institute for Neuroscience and Human Behavior

David Geffen School of MedicineDavid Geffen School of MedicineUniversity of California at Los AngelesUniversity of California at Los Angeles

[email protected]

Supported by:Supported by: National Institute on Drug Abuse (NIDA)National Institute on Drug Abuse (NIDA)

Pacific Southwest Technology Transfer Center (SAMHSA)Pacific Southwest Technology Transfer Center (SAMHSA)International Network of Treatment and Rehabilitation Resource Centres (UNODC)International Network of Treatment and Rehabilitation Resource Centres (UNODC)

Page 2: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Is Addiction a Chronic Disease?Is Addiction a Chronic Disease?

Page 3: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

DemonizationCriminalization

Psychiatric viewsSocialization

Medicalization

Addiction Paradigms

Sinful/ImmoralCriminal/Illegal

Mental Disorder- DSMLearned Behavior/HabitAcute (Brain) Disease

Neuro-Science & Longitudinal Research

Chronic Illness

Leshner, 2001; Anglin et al., 1997

Page 4: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Addiction is a Brain Disease: Implications Addiction is a Brain Disease: Implications for Treatment and Recoveryfor Treatment and Recovery

Page 5: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Neuroscience SupportsNeuroscience SupportsAddiction = Chronic Health ProblemAddiction = Chronic Health Problem

…with biological, sociological and

psychological components

Page 6: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Why Do People Try Drugs?Why Do People Try Drugs?•Curiosity

•Availability Peer Pressure•To have fun •Gain Energy

•Lose Weight•Reduce Pain

Page 7: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Why Do People Like Drugs?Why Do People Like Drugs?To feel good

To have novel:Feelings

SensationsExperiences

AND To share them

To feel betterTo lessen:Anxiety WorriesFearsDepression HopelessnessWithdrawal

Page 8: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

In other words:

A Major Reason People Take a Drug is they Like

What It Does to Their Brains

Page 9: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Pathway for Understanding Pathway for Understanding Addictive Effects Addictive Effects of Drugs on the Brain & Behaviorof Drugs on the Brain & Behavior

Reward Pathway

Page 10: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Gray Matter Deficits in CortexGray Matter Deficits in Cortex

PM Thompson et al., J. Neurosci., 2004

Page 11: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Gray Matter Deficit inGray Matter Deficit inPrefrontal CortexPrefrontal Cortex

PM Thompson et al., J. Neurosci. 2004

Page 12: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

0

50

100

150

200

0 60 120 180Time (min)

% o

f Bas

al D

A O

utpu

t

NAc shell

EmptyBox Feeding

Source: Di Chiara et al.

FOOD

100

150

200

DA

Con

cent

ratio

n (%

Bas

elin

e)

MountsIntromissionsEjaculations

15

0

5

10

Copulation Frequency

SampleNumber

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

ScrScrBasFemale 1 Present

ScrFemale 2 PresentScr

Source: Fiorino and Phillips

SEX

Natural Rewards Elevate Dopamine in the BrainNatural Rewards Elevate Dopamine in the Brain

Page 13: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

0100200300400500600700800900

10001100

0 1 2 3 4 5 hrTime After Amphetamine

% o

f Bas

al R

elea

se

DADOPACHVA

Accumbens AMPHETAMINE

0

100

200

300

400

0 1 2 3 4 5 hrTime After Cocaine

% o

f Bas

al R

elea

se

DADOPACHVA

AccumbensCOCAINE

0

100

150

200

250

0 1 2 3 4 5hrTime After Morphine

% o

f Bas

al R

elea

se

Accumbens

0.51.02.510

Dose (mg/kg)MORPHINE

0

100

150

200

250

0 1 2 3 hrTime After Nicotine

% o

f Bas

al R

elea

se

AccumbensCaudate

NICOTINE

Drugs Also Bring Reward (via Dopamine)Drugs Also Bring Reward (via Dopamine)

Page 14: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Behavioral ResponsesBehavioral ResponsesHow Drugs WorkHow Drugs Work

Loss of controlLoss of control

Continued compulsive Continued compulsive use despite harmful use despite harmful consequencesconsequences Multiple relapses Multiple relapses preceding stable preceding stable recoveryrecovery

Page 15: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

What have we learned through Positron Emission Tomography (PET)?

Page 16: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

BRAIN CHANGESBRAIN CHANGES appear appear prominently in PET scans of prominently in PET scans of current and past drug users current and past drug users

Drug users have far less Drug users have far less dopamine activity (dopamine activity (rightright), as is ), as is indicated by the depletion (dark indicated by the depletion (dark red shows disruption), red shows disruption), compared to the controls compared to the controls (left)(left)

Studies show that this Studies show that this difference contributes todifference contributes to dependence and a diseased dependence and a diseased brainbrain

Page 17: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Source: McCann U.D.. et al.,Journal of Neuroscience, 18, pp. 8417-8422, October 15, 1998.

Decreased dopamine transporter Decreased dopamine transporter binding in METH users resembles that binding in METH users resembles that

in Parkinsonin Parkinson’’s Disease s Disease

Control Meth PD

Page 18: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Partial Recovery of Dopamine Transporters After Prolonged Abstinence

Normal Control Meth user(1 month abstinent)

Meth user(36 months abstinent)

Why is Continued Treatment Why is Continued Treatment Critical?Critical?

Page 19: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

California Civil Addict Program California Civil Addict Program Follow-upFollow-up

A cohort of 581 male heroin addicts admitted to A cohort of 581 male heroin addicts admitted to the California Civil Addict Program (CAP) in 1962-the California Civil Addict Program (CAP) in 1962-64 has been followed-up and interviewed over 64 has been followed-up and interviewed over more than 30 years.more than 30 years.

The CAP was the only major publicly-funded drug The CAP was the only major publicly-funded drug treatment program available in California in the treatment program available in California in the 1960s.1960s.

The CAP provided a combination of inpatient and The CAP provided a combination of inpatient and outpatient drug treatment to narcotics-dependent outpatient drug treatment to narcotics-dependent criminal offenders committed under court order.criminal offenders committed under court order.

Page 20: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Unknown

Dead

Incarcerated

Daily Narcotic Use

Occasional Use

Abstinence

0

10

20

30

40

50

60

70

80

90

100

56 58 60 62 64 66 68 70 72 74 76 78 80 82 84 86 88 90 92 94 96

Years 1956 through 1996

% o

f Sam

ple

22%

48%

6%2%

4%7%

12%

Methadone Maintenance

Natural History of Narcotics Addiction Among CAP SampleNatural History of Narcotics Addiction Among CAP Sample(N=581)(N=581)

Page 21: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Status of Respondents atStatus of Respondents at 3 Interview Points 3 Interview Points

38%

56%

41%

30%

40%39%

14%19%

23%

0

20

40

60

1974-75 1985-86 1996-97

Inactive (neg UA) Active (pos UA & refusal) Incarcerated

Page 22: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Causes of Death Among CAP Causes of Death Among CAP Sample Sample

(N = 271)(N = 271)

59

1011

1228

31

3556

74

0 10 20 30 40 50 60 70 80

Number of Deaths

Infectious Diseases

Cerebrovascular Disease

Liver Disease (Non-Alcoholic)

Lung/Pulmonary Diseases

Other

Heart Disease

Cancer

Alcohol-Related

Accidents and Violence

Drug-Related

aIncludes overdose, poisoning, drug dependence, and suicide by drugsbIncludes motor vehicle, suicide, firearms, homicide, and fallscIncludes alcoholic cirrhosis, alcohol dependence, and poisoning by alcoholdIncludes kidney disease, diabetes, GI, and epilepsy seizureseIncludes viral hepatitis, AIDS, TB, and staphylococol depticemia

a

b

c

d

e

Page 23: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

ConclusionsConclusions

The study findings show the long-term The study findings show the long-term effects of heroin addiction in terms of effects of heroin addiction in terms of morbidity, mortality, criminal justice morbidity, mortality, criminal justice system involvement, and overall level of system involvement, and overall level of functioning.functioning.

Compared to a US Population sample, Compared to a US Population sample, heroin addiction reduces life heroin addiction reduces life expectancy by an average of 18 years.expectancy by an average of 18 years.

Page 24: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Other Long-term Outcome Other Long-term Outcome StudiesStudies

Alcohol: Vaillant: multiple studies reporting a majority of Alcohol: Vaillant: multiple studies reporting a majority of alcoholics who enter treatment experience multiple relapses alcoholics who enter treatment experience multiple relapses and retreatments with about 30-50% achieving stable and retreatments with about 30-50% achieving stable abstinence.abstinence.

Cocaine; Hser: Ten year follow-up of cocaine dependent Cocaine; Hser: Ten year follow-up of cocaine dependent patients in treatment indicates that fewer than 50% achieve patients in treatment indicates that fewer than 50% achieve extended periods of abstinence. Most reenter treatment extended periods of abstinence. Most reenter treatment multiple times.multiple times.

Methamphetamine: Marinelli-Casey 3 year follow up indicates Methamphetamine: Marinelli-Casey 3 year follow up indicates of a cohort of 600 MA dependent individuals about 50% of a cohort of 600 MA dependent individuals about 50% continue to use MA at a moderate or severe level during the 3 continue to use MA at a moderate or severe level during the 3 year post treatment 36 month period. year post treatment 36 month period.

Page 25: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Re-Addiction Following PrisonRe-Addiction Following Prison• Vaillant

• 447 opiate addicts 91% • Maddux & Desmond

• 594 opiate addicts 98% • Nurco & Hanlon

• 355 opiate addicts 88%• Hanlon & Nurco

• 237 mixed addicts 70%

Many Other Studies Including: (Simpson, Wexler, Inciardi, Hubbard, Anglin)

Treatment Research Institute

Page 26: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Acute vs Chronic TreatmentAcute vs Chronic Treatment

Page 27: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

An Acute Model of Treatment vs An Acute Model of Treatment vs Chronic Model of TreatmentChronic Model of Treatment

Page 28: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Drug Abuse Treatment Drug Abuse Treatment CoreCore Components and Components and ComprehensiveComprehensive

ServicesServicesMental Mental HealthHealth

VocationalVocational

EducationalEducational

LegalLegalAIDS / AIDS / HIV RisksHIV Risks

FinancialFinancial

Housing & Housing & TransportationTransportation

Child Child CareCare

FamilyFamily

Continuing Care

Case Management

Urine Monitoring

Self-Help(AA/NA)

Pharmaco-therapy

Group/Individual Counseling

AbstinenceBasedIntake

Assessment

Treatment Plans

CoreCoreTreatmentTreatment

Etheridge, Hubbard, Anderson, Craddock, & Flynn, 1997 (PAB)

MedicalMedical

Page 29: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Treatment ServicesTreatment Services

Continuing Care/Aftercare Programs

Intensive Outpatient/Psychosoci

al Behavioral Treatment

Sober Living Residence

Long-term Residential Treatment

Short-term

Residential

Treatment

Detox/Inpatient

Detox/Outpatient

Medication Assisted Treatment

Page 30: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Public Expectations of Substance Public Expectations of Substance Abuse InterventionsAbuse Interventions

Safe, complete detoxificationSafe, complete detoxification Reduced use of medical servicesReduced use of medical services Eliminate crimeEliminate crime Return to employment/self supportReturn to employment/self support Eliminate family disruptionEliminate family disruption No return to drug useNo return to drug use

Page 31: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

How Do We Think About Treatment?How Do We Think About Treatment? ““The 28 day cure”The 28 day cure” Put them in a box, something happens Put them in a box, something happens

and they come out fixed.and they come out fixed. The washing machine model: Put a “dirty The washing machine model: Put a “dirty

addict” in, run the washer, and take out a addict” in, run the washer, and take out a “clean citizen”.“clean citizen”.

Page 32: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

A Nice Simple Treatment ModelA Nice Simple Treatment Model

Treatment

Addicted Patient

Non- Addicted Patient

Page 33: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Does the “Washing Machine” Model of Treatment Make

Sense?

Page 34: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

A Chronic Care ModelA Chronic Care Model

Detox

Continuing CareRecovering Patient

RehabDurationDetermined byPerformanceCriteria

DurationDetermined byPerformanceCriteria

Page 35: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Stages of TreatmentStages of Treatment

1. Treatment EngagementDetoxification/Stabilization

Purposes: Safe/Adequate reduction of withdrawal symptomsPhysical/Emotional stabilization

Promote problem recognition Engage patient into rehabilitation

Page 36: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Stages of TreatmentStages of Treatment2. Rehabilitation

Purposes: Sustain stable abstinence

Teach self-management skills Identify & reduce threats to progressMedications (maintenance and relapse prevention)Engage patient in continuing care

Page 37: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Stages of TreatmentStages of Treatment

3. Continuing CarePurposes:

Monitor & Support AbstinenceEncourage Self-MonitoringIntervene Upon Threats to Relapse Promote Participation in Long Term

Support Activities

Page 38: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Effective Strategies During Effective Strategies During Treatment EngagementTreatment Engagement

MedicationsMedications Motivational InterviewingMotivational Interviewing Voucher-based TechniquesVoucher-based Techniques Counseling to Promote Transfer to Long Counseling to Promote Transfer to Long

Term CareTerm Care NIATx Strategies NIATx Strategies

Page 39: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Effective Strategies in Effective Strategies in Rehabilitation PhaseRehabilitation Phase

TherapiesTherapies Cognitive Behavioral Cognitive Behavioral Motivational Enhancement TreatmentMotivational Enhancement Treatment Behavioral Couples TherapyBehavioral Couples Therapy Multi Systemic Family TherapyMulti Systemic Family Therapy 12-Step Facilitation12-Step Facilitation Individual Drug CounselingIndividual Drug Counseling

Page 40: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Effective Strategies in Effective Strategies in Rehabilitation PhaseRehabilitation Phase

Interventions/ServicesInterventions/Services Clinical Case Management Clinical Case Management CRAFTCRAFT 12-Step Facilitation12-Step Facilitation Voucher ReinforcementVoucher Reinforcement Matrix Model TreatmentMatrix Model Treatment

MedicationsMedications Alcohol (Naltrexone, Disulfiram, Citalopram) Alcohol (Naltrexone, Disulfiram, Citalopram) Opiates (Naltrexone, Methadone, Buprenorphine)Opiates (Naltrexone, Methadone, Buprenorphine)

Page 41: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

A Chronic Care ModelA Chronic Care Model

Detox

Continuing CareRecovering Patient

RehabDurationDetermined byPerformanceCriteria

DurationDetermined byPerformanceCriteria

Page 42: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Types of Continuing CareTypes of Continuing Care Self/mutual help programsSelf/mutual help programs MedicationsMedications Traditional counseling visitsTraditional counseling visits Home visitsHome visits Recovery “check-ups”Recovery “check-ups”

Specialty care-basedSpecialty care-based Primary care-basedPrimary care-based

Telephone-based protocolsTelephone-based protocols Monitoring Monitoring Monitoring and counselingMonitoring and counseling

Other stuffOther stuff

Page 43: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Recovery Management CheckupsRecovery Management Checkups

Protocol developed by Dennis, Scott et al.Protocol developed by Dennis, Scott et al. Interview patients Interview patients every quarter for 2 yearsevery quarter for 2 years If patient reports any of the following……If patient reports any of the following……

• Use of alcohol or drugs on Use of alcohol or drugs on >> 2 weeks 2 weeks• Being drunk or high all day on any daysBeing drunk or high all day on any days• Alcohol/drug use led to not meeting Alcohol/drug use led to not meeting

responsibilitiesresponsibilities• Alcohol/drug use caused other problemsAlcohol/drug use caused other problems• Withdrawal symptomsWithdrawal symptoms

……Patient transferred to linkage managerPatient transferred to linkage manager

Page 44: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Recovery Management CheckupsRecovery Management Checkups

Linkage Manager provides the following:Linkage Manager provides the following: Personalized feedbackPersonalized feedback Explore possibility of returning to treatmentExplore possibility of returning to treatment Address barriers to returning to treatmentAddress barriers to returning to treatment Schedule an intake assessmentSchedule an intake assessment Reminder cards, transportation, and escort to Reminder cards, transportation, and escort to

intake appointmentintake appointment

Page 45: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Telephone as a continuing care toolTelephone as a continuing care tool Potential to promote better long-term Potential to promote better long-term

engagement and participation because:engagement and participation because: Convenient for clientConvenient for client Reduces stigma of weekly trips to the treatment Reduces stigma of weekly trips to the treatment

programprogram Individualized attentionIndividualized attention Can be automated (Helzer, Searles et al.)Can be automated (Helzer, Searles et al.) Lower costs of ongoing care (?)Lower costs of ongoing care (?)

Page 46: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Evidence Supporting Therapeutic Evidence Supporting Therapeutic Use of the TelephoneUse of the Telephone

Studies suggest the telephone can be effective Studies suggest the telephone can be effective in delivering treatment:in delivering treatment: Addiction (Foote & Erfurt, 1991)Addiction (Foote & Erfurt, 1991) Smoking (Smoking (LichtensteinLichtenstein et al., 1996) et al., 1996) Depression (Baer et al., 1995; Simon et al., 2004)Depression (Baer et al., 1995; Simon et al., 2004) OCD (Greist et al., 1998)OCD (Greist et al., 1998) Panic and Anxiety (Rollman et al., 2005)Panic and Anxiety (Rollman et al., 2005) Bulimia (Hugo et al., 1999)Bulimia (Hugo et al., 1999) Cardiac care (Jerant et al., 2001; Riegel et al., Cardiac care (Jerant et al., 2001; Riegel et al.,

2002)2002)

Page 47: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

A Continuum of CareA Continuum of Care

HospitalDetox

ResidentialRehab

IOPCare

OutpatientCont Care

AA -TeleMonitoring

TeleMonitoring

Page 48: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Elements of Continuum of Services

Prevention Treatment/Intervention

Recovery Services

Otpt Tx

Detox

Intensive Otpt Tx

Long-term Res Care

Short-term Res Care

Methadone Maintenance

NTPDetox

Recovery

Page 49: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

0100200300400500600700800900

1000

Detox Residential Outpatient NTP Detox

Total AdmissionsAny Transfers

County Profile SamplesCounty Profile SamplesCounty ACounty A

Adm

issi

ons

50%

20%25% 9%

Number of transfers within the past 30-days following tx discharge

Page 50: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

0100200300400500600700800900

1000

Detox Residential Outpatient NTP Detox

Total AdmissionsAny Transfers

County Profile SamplesCounty Profile SamplesCounty BCounty B

Adm

issi

ons

20% 40%

75%

7%

Number of transfers within the past 30-days following tx discharge

Page 51: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Recovery Services

Prevention Treatment/Intervention

Recovery

Telephone Continuing Care

Recovery Coaches/ Centers

Recovery Services

Otpt Tx

Detox

Intensive Otpt Tx

Long-term Res Care

Short-term Res Care

Methadone Maintenance

NTPDetox

Page 52: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Considerations with the ContinuumConsiderations with the Continuum

Sober housing plus outpatient care vs Sober housing plus outpatient care vs residential treatmentresidential treatment

Integration of medication (including Integration of medication (including methadone) into the continuummethadone) into the continuum

Determining when to transfer levels of Determining when to transfer levels of carecare

Remember, sometimes treatment intensity Remember, sometimes treatment intensity needs to be increased, not just decreased needs to be increased, not just decreased

Page 53: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Do you really use the full continuum Do you really use the full continuum of care?of care?

If you work in a residential treatment program, If you work in a residential treatment program, when was the last time, you referred a client into when was the last time, you referred a client into an intensive outpatient program (other than your an intensive outpatient program (other than your own) after they completed residential care?own) after they completed residential care?

If you work in an NTP, when was the last time If you work in an NTP, when was the last time you ever referred a patient into a residential you ever referred a patient into a residential treatment program, if they were doing poorly on treatment program, if they were doing poorly on methadone?methadone?

If you work in an outpatient treatment program, If you work in an outpatient treatment program, when was the last time you ever put one of your when was the last time you ever put one of your relapsing opiate addicts on buprenorphine, while relapsing opiate addicts on buprenorphine, while they were in your outpatient program? they were in your outpatient program?

Page 54: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Lessons from Chronic Illness:Lessons from Chronic Illness:

1.1. Medications and discussions of Medications and discussions of feelings can relieve symptoms feelings can relieve symptoms but…. behavioral change is but…. behavioral change is necessary for sustained benefitnecessary for sustained benefit

Page 55: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Lessons from Chronic Illness:Lessons from Chronic Illness:

2. Treatment effects 2. Treatment effects usuallyusually don’t don’t last very long after treatment last very long after treatment stops.stops.

Page 56: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Lessons from Chronic Illness:Lessons from Chronic Illness:

3. 3. Patients who are not inPatients who are not in some some form of treatment or monitoringform of treatment or monitoring are at elevated risk for relapseare at elevated risk for relapse..

Page 57: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Multiple Episodes of Acute Care IS

NOT Chronic Care

Patient Retention is Critical

Monitoring in Treatment is Essential

Lessons from Chronic Illness:Lessons from Chronic Illness:

Page 58: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Medical Detoxification Treatment Medical Detoxification Treatment ProgramsPrograms

Medical Detoxification is a treatment service used to Medical Detoxification is a treatment service used to systematically withdraw individuals from a substance in systematically withdraw individuals from a substance in an inpatient or outpatient setting. an inpatient or outpatient setting.

Treatment is provided under the care of a medical doctor.Treatment is provided under the care of a medical doctor. Detoxification is a short treatment and does not address Detoxification is a short treatment and does not address

the psychosocial and behavioral issues linked to the psychosocial and behavioral issues linked to addiction. addiction.

Detoxification is most valuable when it encompasses Detoxification is most valuable when it encompasses formal processes of assessment and results with a formal processes of assessment and results with a referral to successive substance abuse treatment. referral to successive substance abuse treatment.

Detox/Inpatient

Detox/Outpatient

Page 59: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Inpatient Residential TreatmentInpatient Residential Treatment Short-term Residential Treatment Short-term Residential Treatment

(commonly referred to as the Minnesota (commonly referred to as the Minnesota Model) focuses on the introduction to the Model) focuses on the introduction to the 12 Step Program and long term 12 Step Program and long term participation in 12 Step programs for participation in 12 Step programs for recovery support.recovery support.

Long-term Residential Treatment (often Long-term Residential Treatment (often referred to as the modified Therapeutic referred to as the modified Therapeutic Community approach) involves an Community approach) involves an extended period (3-12 months) of living extended period (3-12 months) of living within a highly structured recovery within a highly structured recovery community. “Treatment” is delivered via community. “Treatment” is delivered via peer interactions within the community. peer interactions within the community.

Sober Living Residence is a living Sober Living Residence is a living environment that has supervision and a environment that has supervision and a recovery environment. It should be used in recovery environment. It should be used in conjunction with outpatient treatment and conjunction with outpatient treatment and is not considered “treatment” on its ownis not considered “treatment” on its own

Sober Living Residence

Long-term Residential Treatment

Short-term Residential Treatment

Page 60: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Intensive Outpatient TreatmentIntensive Outpatient Treatment

Outpatient Treatment varies in length of stay, Outpatient Treatment varies in length of stay, but typically lasts at least 90 days and is but typically lasts at least 90 days and is followed by outpatient continuing care. followed by outpatient continuing care.

Patients generally receive 6 to 30 contact hours Patients generally receive 6 to 30 contact hours per week. per week. Core services include: group, individual and family Core services include: group, individual and family

counseling, psychoeducation, relapse prevention counseling, psychoeducation, relapse prevention training, positive reinforcement techniques; family training, positive reinforcement techniques; family involvement; urine and breath alcohol testing; 12 involvement; urine and breath alcohol testing; 12 Step (or alternative) participation; case Step (or alternative) participation; case management; medication, vocational and management; medication, vocational and educational services. educational services.

Intensive Outpatient/Psychosocial

Behavioral Treatment

Page 61: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Medication Assisted TreatmentMedication Assisted Treatment

Medication (e.g. Methadone, Buprenorphine) Medication (e.g. Methadone, Buprenorphine) provided in phases by a certified, licensed Opioid provided in phases by a certified, licensed Opioid Treatment Program (OTP) or a through a trained Treatment Program (OTP) or a through a trained medical doctor.medical doctor.

Medication Assisted treatment provides Medication Assisted treatment provides maintenance pharmacotherapy using an opioid maintenance pharmacotherapy using an opioid agonist, a partial agonist, or an antagonist agonist, a partial agonist, or an antagonist medication. medication.

The medication may be combined with other The medication may be combined with other treatment services, including medical and treatment services, including medical and psychosocial services. psychosocial services.

Medication Assisted Treatment

Page 62: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Effective ProgramsEffective Programs

Longer duration (2-4 years).Longer duration (2-4 years). Higher doses, > 60mg methadone.Higher doses, > 60mg methadone. Accessible prescriber and dispenser.Accessible prescriber and dispenser. Ancillary services.Ancillary services. Quality of therapeutic relationship.Quality of therapeutic relationship.

Page 63: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

What is Treatment?What is Treatment?BuprenorphineBuprenorphine

A new opiate pharmacotherapyA new opiate pharmacotherapy Can be used for opiate withdrawal or maintenanceCan be used for opiate withdrawal or maintenance Can deliver from MD offices, not necessarily NTPsCan deliver from MD offices, not necessarily NTPs Medication is very safe, produces less Medication is very safe, produces less

dependence than methadone (withdrawal easier)dependence than methadone (withdrawal easier) Partial agonist, blocks other opiatesPartial agonist, blocks other opiates May not be potent enough for heavy, long time May not be potent enough for heavy, long time

usersusers Diversion is possible, but preventable.Diversion is possible, but preventable.

Page 64: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Treatment EpisodeTreatment Episode

Detox/Outpatient

Medication Assisted Treatment

Page 65: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Treatment EpisodeTreatment Episode

Continuing Care/Aftercare Programs

Sober Living ResidenceIntensive

Outpatient/Psychosocial Behavioral

Treatment

Long-term Residential Treatment

Page 66: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Treatment EpisodeTreatment Episode

Continuing Care/Aftercare Programs

Detox/Inpatient Long-term

Residential Treatment

Intensive Outpatient/Psychosoci

al Behavioral Treatment

Sober Living Residence

Page 67: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

The Red Arrow – Transfer/ReferralThe Red Arrow – Transfer/Referral

Strategies for enhancing treatment service linkage:• Case management process

• Integrating staff from different treatment levels

• Create a personal linkage

• Transportation to facility

• Referral in appropriate geographical location

Page 68: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Measuring Program Performance: A Key to Measuring Program Performance: A Key to a Successful Continuum of Carea Successful Continuum of Care

Program Performance: What is it and how Program Performance: What is it and how will we measure it?will we measure it?

Page 69: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Measuring Measuring Program PerformanceProgram Performance

Definition: Definition: AOD treatment program performance is AOD treatment program performance is

evaluated by measuring the extent to evaluated by measuring the extent to which the clients of a treatment program which the clients of a treatment program

achieve specific benchmarks.achieve specific benchmarks.

In California, the key to this measurement In California, the key to this measurement will be the data collected in CalOMSwill be the data collected in CalOMS

Page 70: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

How will CalOMS be used to How will CalOMS be used to improve program performance?improve program performance?

CalOMS data collection system that gives policymakers CalOMS data collection system that gives policymakers the ability to measure the performance of AOD the ability to measure the performance of AOD programs. programs.

The CalOMS data can be used to: The CalOMS data can be used to: 1. 1. monitor monitor treatment program performance treatment program performance 2. improve the 2. improve the managementmanagement of treatment services. of treatment services. 3. establish performance 3. establish performance benchmarksbenchmarks 4. recognize better/poorer performing programs.4. recognize better/poorer performing programs. 5. rewarding performance of better performing 5. rewarding performance of better performing

programs and targeting technical assistance to programs and targeting technical assistance to struggling programs.struggling programs.

Page 71: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

How do we measure the performance How do we measure the performance of California’s treatment system?of California’s treatment system?

Page 72: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

A Source of Confusion:A Source of Confusion:Outcomes vs PerformanceOutcomes vs Performance

Outcomes:Outcomes: OUTCOME MEASURES ARE USED AT OUTCOME MEASURES ARE USED AT THE PATIENT LEVEL AND MEASURE CHANGES IN THE PATIENT LEVEL AND MEASURE CHANGES IN PATIENT BEHAVIOR OR FUNCTIONING OVER TIMEPATIENT BEHAVIOR OR FUNCTIONING OVER TIME

Performance: Performance: PERFORMANCE MEASURES ARE PERFORMANCE MEASURES ARE USED AT THE TREATMENT PROGRAM LEVEL TO USED AT THE TREATMENT PROGRAM LEVEL TO EXAMINE THE FUNCTIONING OF THE TREATMENT EXAMINE THE FUNCTIONING OF THE TREATMENT PROGRAMPROGRAM

Page 73: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Treatment Initiation/EngagementTreatment Initiation/Engagement

Definitions: Definitions: InitiationInitiation: Do people who enter treatment receive : Do people who enter treatment receive

at least 2 treatment visits in the first 2 weeks?at least 2 treatment visits in the first 2 weeks?Engagement:Engagement: Do people who enter treatment Do people who enter treatment

receive at least 4 sessions in the first 30 days/receive at least 4 sessions in the first 30 days/

Meaningful: YesMeaningful: Yes Clearly Defined: YesClearly Defined: Yes Reliability and Validity of Measures: YesReliability and Validity of Measures: Yes Readily Accessible Data for Measures: ????Readily Accessible Data for Measures: ????

Page 74: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Treatment RetentionTreatment Retention

Definition: Definition: Retention: Number of days between admission Retention: Number of days between admission

and discharge.and discharge.

Meaningful: YesMeaningful: Yes Clearly Defined: YesClearly Defined: Yes Reliability and Validity of Measures: YesReliability and Validity of Measures: Yes

(maybe)(maybe) Readily Accessible Data for Measures: YesReadily Accessible Data for Measures: Yes

Page 75: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Continuity of CareContinuity of Care

Definition: Definition: Do individuals who enter treatment Do individuals who enter treatment

proceed through multiple service sets proceed through multiple service sets (levels of care)(levels of care)

Meaningful: YesMeaningful: Yes Clearly Defined: YesClearly Defined: Yes Reliability and Validity of Measures: YesReliability and Validity of Measures: Yes Readily Accessible Data for Measures: Readily Accessible Data for Measures:

YesYes

Page 76: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Treatment EpisodeTreatment Episode

Continuing Care/Aftercare Programs

Sober Living ResidenceIntensive

Outpatient/Psychosocial Behavioral

Treatment

Long-term Residential Treatment

Page 77: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Treatment CompletionTreatment Completion

Definition: Definition: Per CALOMS discharge, do people complete Per CALOMS discharge, do people complete

treatment treatment

Meaningful: YesMeaningful: Yes Clearly Defined: NoClearly Defined: No Reliability and Validity of Measures: NoReliability and Validity of Measures: No Readily Accessible Data for Measures: YesReadily Accessible Data for Measures: Yes

Page 78: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Other Discharge CategoriesOther Discharge CategoriesDefinitions: Definitions: Leave with Satisfactory ProgressLeave with Satisfactory Progress?: Do people ?: Do people

who enter treatment and leave before who enter treatment and leave before completion make satisfactory progress?completion make satisfactory progress?

Leave with Unsatisfactory ProgressLeave with Unsatisfactory Progress?: Do people ?: Do people who enter treatment and leave before who enter treatment and leave before completion have unsatisfactory progresscompletion have unsatisfactory progress

Meaningful: ??Meaningful: ?? Clearly Defined: NoClearly Defined: No Reliability and Validity of Measures: NoReliability and Validity of Measures: No Readily Accessible Data for Measures: YesReadily Accessible Data for Measures: Yes

Page 79: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Strategies for improving AOD Strategies for improving AOD program performanceprogram performance

Reduce staff turnoverReduce staff turnover Increase staff knowledge of other forms of Increase staff knowledge of other forms of

care to promote a “system of care” rather care to promote a “system of care” rather than isolated programsthan isolated programs

Increase staff knowledge and use of Increase staff knowledge and use of evidence-based practicesevidence-based practices

Employ process improvement (NIATx)Employ process improvement (NIATx)

Page 80: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

A Continuing Care “System” of A Continuing Care “System” of AOD Treatment is more than a AOD Treatment is more than a

“Bunch of Programs”“Bunch of Programs”

Page 81: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Inpatient Inpatient DetoxDetox

Short-term Residential

Care

Long-term Long-term Residential Residential

Care Care

Current Publicly Funded Services

Residential

Facilities

Outpatient

Services

Narcotic Treatment

Program

Brief Treatment

Outpatient Treatment

IntensiveOutpatient Treatment

OutpatientDetox

MethadoneMaintenance

Page 82: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Sober Living Sober Living FacilitiesFacilities

Elements of Treatment System Not Currently Funded

Sober Living

Facilities

Addiction

Physicians

Continuing Care

Services

Medication Assisted

Treatment for Opiate Addiction:

Suboxone, Naltrexone

Recovery Centers

Recovery Check-ups

Medication Assisted

Treatment for Alcohol Abuse

and Dependence: Vivatrol,

Acamprosate, Ondansetron

Telephone SupportServices

Page 83: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Geographic Distribution of Services, __________ County, Geographic Distribution of Services, __________ County, CACA

NTP

RS

RS

OP

OP

OP

OP

OP OP

OP

OPOP

NTP

NTP

AP

AP

AP

SLSL SL

AP

SLSL

Client’s house

Page 84: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Geographic Distribution of Services, __________ County, Geographic Distribution of Services, __________ County, CACA

NTP

RS

RS

OP

OP

OP

OP

OP OP

OP

OPOP

NTP

NTP

AP

AP

AP

SLSL SL

AP

SLSL

Client’s house

Page 85: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Some Requirements of a “System” of CareSome Requirements of a “System” of Care

Individuals are treated with the most appropriate, Individuals are treated with the most appropriate, evidence-based treatment approaches and in the evidence-based treatment approaches and in the appropriate level of care.appropriate level of care.

Workforce recognizes the benefits of all evidence based Workforce recognizes the benefits of all evidence based treatment approaches and attempts to place individuals treatment approaches and attempts to place individuals in most effective form of care.in most effective form of care.

Workforce is informed and knowledgeable about Workforce is informed and knowledgeable about treatment services delivered by other treatment treatment services delivered by other treatment organizations in the service area.organizations in the service area.

Page 86: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Some Requirements of a “System” of CareSome Requirements of a “System” of Care

Clients will be transferred along the continuum of care Clients will be transferred along the continuum of care with communication and cooperation (“warm with communication and cooperation (“warm referral”)between treatment organizations.referral”)between treatment organizations.

Performance data will be collected and used by County Performance data will be collected and used by County Administration and by treatment providers to monitor Administration and by treatment providers to monitor progress toward a Continuing Care System of AOD progress toward a Continuing Care System of AOD treatment.treatment.

Performance data must not add substantial data burden Performance data must not add substantial data burden to service providers and data must be given to providers to service providers and data must be given to providers in a timely manner and in a form that is clear and in a timely manner and in a form that is clear and meaningful.meaningful.

Page 87: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

A word about data quality…A word about data quality…

Newer Measures for a Newer Measures for a System of CareSystem of Care

Page 88: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Fresno CalOMS Data from 2008Fresno CalOMS Data from 2008

Page 89: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

0

1000

2000

3000

4000

5000

6000

7000

NTP Detox Detox Residential Outpatient Day Care Rehab

Number of Transfers within the past 30-days following Tx discharge

Total AdmissionsAny Transfers

Tx Modality

No.

of A

dmis

sion

sFresnoFresno

26%11%

9%20%32%

Page 90: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

0

20000

40000

60000

80000

100000

120000

NTP Detox Detox Residential Outpatient Day Care Rehab

Number of Transfers within the past 30-days following Tx discharge

Total AdmissionsAny Transfers

Tx Modality

No.

of A

dmis

sion

sStateState

29%11%

13%21%30%

Page 91: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

72%

3%

12%

13%

15%

1%

3%7%

74%

Nothing

Detox

Residential

Outpatient

Maintenance

Destination Treatment Type

FresnoFresnoDetox Total: 1078

*Transfers to NTP Detox = 0, Day Care Rehab = 1

StateStateDetox Total: 26670

*Transfers to NTP Detox = 4, Day Care Rehab = 71,

Maintenance= 126

Transfers from Detox

Page 92: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

1%8%

10%

80%

1%

Nothing

Detox

Residential

Outpatient

Day Care Rehab

7%

75%

6%

11% 1%

Destination Treatment Type

*Transfers to NTP Detox = 2, Maintenance= 1 *Transfers to NTP Detox = 46, Maintenance= 98

Residential Total: 41,636Residential Total: 2154FresnoFresno StateState

Transfers from Residential

Page 93: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

0

10

20

30

40

50

60

70

80

90

100

Rx (Oxycodone)

Heroin Cocaine Meth Alcohol Cannabis Benzo (tranquilizers)

Other*

Retention Days by Primary Drug

FresnoState

Mea

n N

o. o

f Day

s in

Tx

Drug Category

*Other = barbiturates, PCP, inhalants, ecstasy, hallucinogens, club drugs, and other stimulants and tranquilizers

Page 94: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

0

20

40

60

80

100

120

NTP Detox Detox ResidentialOutpatient Day Care Rehab

Maint.

Retention Days by Treatment Type

FresnoState

Mea

n N

o. o

f Day

s in

Tx

Type of Tx Modality

Page 95: Addiction is a chronic disease and it matters Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School

Building Interactive Service Building Interactive Service SystemsSystems

To create a treatment system that To create a treatment system that produces the best outcomes for patients,produces the best outcomes for patients,

it is necessary for AOD services within a it is necessary for AOD services within a county to be delivered in a “system of county to be delivered in a “system of care” rather than a “bunch of isolated care” rather than a “bunch of isolated programs”.programs”.